Technically Speaking, page-36

The inverse indicator is alive and well.

I'm not selling a single share. I would like to once again reiterate that the share price dollar figure is not important, it's the market cap that counts.

And this market cap is still very low, and really only reaches a fair valuation around $8 (and that's only for the current state of the business, not including potential future deals with companies like Pfizer or those in the hospital sterilization space)